Chair: David Pyott, Chairman & CEO, Allergan, Inc.
Staff Contact: Joseph Damond, Senior Vice President, International Affairs, firstname.lastname@example.org
Description: The committee oversees, in conjunction with other relevant BIO committees, BIO’s international work plan objectives to foster an environment conducive to biotechnology, re-shape the debate on IP and pro-innovation policies, and influence regulatory reform and harmonization discussions in key international markets. The committee’s jurisdiction includes oversight of BIO’s International Affairs Initiative, international organization matters (e.g., WHO, WTO, WIPO, APEC, OECD), international advocacy and education programs, international studies, and coordinating efforts of foreign peer organizations.
David Pyott, Chairman & CEO, Allergan, Inc.
Julie Gerberding, President, Merck Vaccines, Merck & Co, Inc.
Geno Germano, Group President, Global Innovative Pharma Business, Pfizer, Inc.
Scott Koenig, President & CEO, MacroGenics, Inc.
David Meeker, Chief Executive Officer, Vice President, Genzyme Corporation: A Sanofi Company
Arlene Morris, Chief Executive Officer, Syndax, Inc.
Francois Nader, President & CEO, NPS Pharmaceuticals, Inc.
Nicholas Nicolaides, President & CEO, Morphotek, Inc.
Stephan Tanda, Managing Board Member, DSM Pharmaceutical Products
Bradford Zakes, Chief Executive Officer, Cerevast Therapeutics, Inc.
Neil Warma, President & CEO, Opexa Therapeutics, Inc.